Homo sapiens Protein: SOST
Summary
InnateDB Protein IDBP-52909.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol SOST
Protein Name sclerostin
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000301691
InnateDB Gene IDBG-52907 (SOST)
Protein Structure
UniProt Annotation
Function Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation. {ECO:0000269PubMed:15908424}.
Subcellular Localization Secreted, extracellular space, extracellular matrix {ECO:0000269PubMed:20551380}.
Disease Associations Sclerosteosis 1 (SOST1) [MIM:269500]: An autosomal recessive sclerosing bone dysplasia characterized by a generalized hyperostosis and sclerosis leading to a markedly thickened skull, with mandible, ribs, clavicles and all long bones also being affected. Due to narrowing of the foramina of the cranial nerves, facial nerve palsy, hearing loss and atrophy of the optic nerves can occur. Sclerosteosis is clinically and radiologically very similar to van Buchem disease, mainly differentiated by hand malformations and a large stature in sclerosteosis patients. {ECO:0000269PubMed:11179006, ECO:0000269PubMed:11181578, ECO:0000269PubMed:20583295}. Note=The disease is caused by mutations affecting the gene represented in this entry.Van Buchem disease (VBCH) [MIM:239100]: VBCH is an autosomal recessive sclerosing bone dysplasia characterized by endosteal hyperostosis of the mandible, skull, ribs, clavicles, and diaphyses of the long bones. Affected patients present a symmetrically increased thickness of bones, most frequently found as an enlarged jawbone, but also an enlargement of the skull, ribs, diaphysis of long bones, as well as tubular bones of hands and feet. The clinical consequence of increased thickness of the skull include facial nerve palsy causing hearing loss, visual problems, neurological pain, and, very rarely, blindness as a consequence of optic atrophy. Serum alkaline phosphatase levels are elevated. {ECO:0000269PubMed:11836356}. Note=The disease is caused by mutations affecting the gene represented in this entry. A 52 kb deletion downstream of SOST results in SOST transcription suppression causing van Buchem disease.Craniodiaphyseal dysplasia autosomal dominant (CDD) [MIM:122860]: A severe bone dysplasia characterized by massive generalized hyperostosis and sclerosis, especially involving the skull and facial bones. The sclerosis is so severe that the resulting facial distortion is referred to as 'leontiasis ossea' (leonine faces) and the bone deposition results in progressive stenosis of craniofacial foramina. Respiratory obstruction due to choanal stenosis compromises the clinical outcomes of affected patients. {ECO:0000269PubMed:21221996}. Note=The disease is caused by mutations affecting the gene represented in this entry. Heterozygous mutations located in the secretion signal of the SOST gene prevent sclerostin secretion and can be responsible for craniodiaphyseal dysplasia.
Tissue Specificity Widely expressed at low levels with highest levels in bone, cartilage, kidney, liver, bone marrow and primary osteoblasts differentiated for 21 days. Detected in the subendothelial layer of the aortic intima (at protein level). {ECO:0000269PubMed:20551380}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 3 experimentally validated interaction(s) in this database.
Experimentally validated
Total 3 [view]
Protein-Protein 3 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0008134 transcription factor binding
GO:0008201 heparin binding
Biological Process
GO:0001503 ossification
GO:0009612 response to mechanical stimulus
GO:0016055 Wnt signaling pathway
GO:0030178 negative regulation of Wnt signaling pathway
GO:0030279 negative regulation of ossification
GO:0030514 negative regulation of BMP signaling pathway
GO:0031333 negative regulation of protein complex assembly
GO:0045893 positive regulation of transcription, DNA-templated
GO:0071374 cellular response to parathyroid hormone stimulus
GO:0090090 negative regulation of canonical Wnt signaling pathway
GO:2000054 negative regulation of Wnt receptor signaling pathway involved in dorsal/ventral axis specification
Cellular Component
GO:0005578 proteinaceous extracellular matrix
GO:0005615 extracellular space
GO:0005794 Golgi apparatus
GO:0031012 extracellular matrix
Protein Structure and Domains
PDB ID
InterPro IPR004133 DAN
IPR006207 Cystine knot, C-terminal
IPR008835 Sclerostin/Sclerostin domain-containing protein 1
IPR029034 Cystine-knot cytokine
PFAM PF03045
PF05463
PRINTS
PIRSF
SMART SM00041
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q9BQB4
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 50964
UniGene Hs.349204
RefSeq NP_079513
HUGO HGNC:13771
OMIM 605740
CCDS CCDS11468
HPRD 05762
IMGT
EMBL AC055813 AF326736 AF326739 AF331844 AY358203 AY358627 BC101086 BC101087 BC101088 BC101089
GenPept AAI01087 AAI01088 AAI01089 AAI01090 AAK13451 AAK13454 AAK16158 AAQ88570 AAQ88990